Medullary thyroid carcinoma
Conditions
Interventions
Sponsors
Fudan University Shanghai Cancer Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Voluntarily sign an informed consent form. 2. Age = 18 years old. 3. MTC patients highly suspected or confirmed through pathological or routine imaging examinations, with CT levels>150 pg/mL and CEA greater than the upper limit of the reference value. 4. According to the doctor's assessment, the estimated survival period is 3 months. 5. Agree to implement strict contraception for at least 28 days after PET/CT examination. 6. Willing and able to follow the research protocol.
Exclusion criteria
Exclusion criteria: 1. Patients diagnosed with other malignant tumors in the past year. 2. Patients diagnosed with other pathological types of thyroid cancer during follow-up. 3. Patients undergoing any anti-tumor treatment between two PET/CT examinations. 4. Pregnant or lactating women. 5. Unable to cooperate with lying on the PET/CT scanning bed during the scanning period or intolerant to PET examination. 6. Patients who have received or are currently receiving radiotherapy, chemotherapy, immunotherapy, or molecular targeted therapy. 7. Have participated in other intervention clinical trials within the first month prior to screening. 8. Patients who have been lost to follow-up. 9. According to the researcher's evaluation, the subjects may have other circumstances that may affect the study or may not be suitable for participation in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| SUVmax (Standardized Uptake Value max); | — |
Countries
China
Contacts
Public ContactShaoli Song
Fudan University Shanghai Cancer Center
Outcome results
None listed